KB Home CEO Jeffrey Mezger sees his bonus cut after vulgar rant at Kathy Griffin

KB Home said in a regulatory filing Thursday that Jeffrey Mezger -- who was recorded deriding comedian Kathy Griffin in a vulgar rant -- would be fired for any similar incidents in the future and cut his annual bonus by 25%.
(Invision / Associated Press; Los Angeles Times)

One of the nation’s biggest homebuilders is putting its top executive on notice after a vulgar rant against comedian Kathy Griffin was caught on tape and went viral.

KB Home CEO Jeffrey Mezger, who is a neighbor of Griffin’s in California, was recorded by a security camera hurling slurs against Griffin while in a heated argument with her boyfriend. Mezger was angered after Griffin or her boyfriend complained to police over a family get-together at Mezger’s house.

Griffin and her boyfriend in the incident that preceded the confrontation appear to have called police over noise made by children playing in a backyard pool.

There has been some backlash against the executive since the vulgar, two-minute outburst was first aired by HuffPost.

TV host and financial advisor Suze Orman wrote on Twitter, “Disgraceful talk from the CEO of KB HOMES. You really want to buy a home from this man? Beyond Disgusting!”


KB Home and Mezger did not immediately respond to an early request for comment.

KB Home said in a regulatory filing Thursday that while Mezger has been “a great leader,” his behavior was unacceptable and that he would be fired for any similar incidents in the future. It also cut his annual bonus by 25%.

How much that will cost Mezger, who has been CEO since 2006, isn’t clear. He was paid $9 million last year in salary and stock awards, but he hasn’t received a bonus since 2014. In that year, Mezger received a bonus of $125,000.


In L.A.’s Broadway Theater District, Chinese developer plans condos priced for first-time buyers

Toys R Us plans to hire thousands of seasonal workers despite bankruptcy

To justify a 35% rate hike, Anthem expects Californians to use a lot more drugs next year